Despite the great advances that the tissue engineering field has experienced over the last
two decades, the amount of in vitro engineered tissues that have reached a stage of clinical …

Bioprinting is a promising technology to fabricate design-specific tissue constructs due to its
ability to create complex, heterocellular structures with anatomical precision. Bioprinting …

Clinically, large diameter artery defects (diameter larger than 6 mm) can be substituted by
unbiodegradable polymers, such as polytetrafluoroethylene. There are many problems in …

There has been an increasing demand for bioengineered blood vessels for utilization in
both regenerative medicine and drug screening. However, the availability of a true …

Current limitations of exogenous scaffolds or extracellular matrix based materials have
underlined the need for alternative tissue-engineering solutions. Scaffolds may elicit …

With a limited supply of organ donors and available organs for transplantation, the aim of
tissue engineering with three-dimensional (3D) bioprinting technology is to construct fully …

Overcoming the problem of vascularization remains the main challenge in the field of tissue
engineering. As three-dimensional (3D) bioprinting is the rising technique for the fabrication …

Recent advancements in the bioinks and three-dimensional (3D) bioprinting methods used
to fabricate vascular constructs are summarized herein. Critical biomechanical properties …

Recent advances in the field of bioprinting have led to the development of perfusable
complex structures. However, most of the existing printed vascular channels lack the …

Vascularization is a leading limitation for the clinical application of in vitro engineered tissue
constructs because of the insufficient blood supply in the initial phase after implantation. In …